Skip to main content

Parental Smoking Possibly Linked to Increased Risk for MS

Medically reviewed by Carmen Pope, BPharm. Last updated on July 12, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, July 12, 2024 -- Exposure to parental smoking (ParS) is associated with an increased risk for multiple sclerosis (MS) in later life in certain populations, according to a study presented at EAN 2024, the 10th Congress of the European Academy of Neurology, held from June 29 to July 2 in Helsinki.

Caterina Ferri, M.D., from the S. Anna University Hospital in Ferrara, Italy, and colleagues examined the impact of past exposure to ParS, including maternal smoking during pregnancy (MSDP), on MS risk among adults. The association between MS and smoking habit, MSDP, and maternal/paternal smoking (MaS/PaS) was examined using data for 1,565 Canadian, 2,040 Italian, and 2,674 Norwegian individuals.

The researchers found that among Norwegians, there was an association between MS and MSDP and MaS (odds ratios [95 percent confidence intervals], 1.38 [1.12 to 1.71] and 1.39 [1.17 to 1.65], respectively). Among Canadians, there was a trend toward an increased risk for MS in association with PaS (adjusted odds ratio, 1.21; 95 percent confidence interval, 0.97 to 1.51). In the Italian population, no significant association was seen with any ParS.

"It is hard to investigate this field," Ferri said in a statement. "Another factor to be considered is that if your parents smoke, you are more predisposed to becoming a smoker, which affects per se the risk of developing MS. So, there is a lot of confounding in this kind of study if you do not adjust the results. You may find results that do not reflect the reality."

Press Release (Page 16)

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Ofatumumab Effective for MS Across Racial, Ethnic Subgroups

WEDNESDAY, July 17, 2024 -- For patients with relapsing multiple sclerosis (RMS), ofatumumab is more effective than teriflunomide across racial and ethnic subgroups, according to...

Nicotine Exposure Lower for Children Exposed to Secondhand Vapor

FRIDAY, July 12, 2024 -- Nicotine absorption is much lower in children who are exposed to secondhand vapor versus secondhand smoke, but it is still higher than among those exposed...

Study Looks at Impact of Incentivizing Smoking Cessation in Addition to Usual Care

WEDNESDAY, July 10, 2024 -- Incentivizing smoking cessation increases smoking cessation through 12 weeks, but not at 26 weeks, when missing data are treated as smoking, according...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.